Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
After years of setbacks, Alzheimer's researchers are sounding optimistic again. The reason: a brain protein called tau.
Men's semen appears to give the AIDS virus an extra boost, researchers from the Gladstone Institutes reported Wednesday in a finding they say may explain why it’s so hard to develop creams or gels to prevent infection.
Semen boosts the infectiousness of the AIDS virus and renders ineffective many promising gels aimed at blocking HIV, according to UCSF/Gladstone Institutes researchers. However, they believe new drugs could undercut semen's HIV-enhancing effect and provide a new way to obstruct the virus.
Semen appears to interfere with microbicide gels to prevent HIV, possibly explaining why they work in the lab but not in real-life situations, say scientists from the Gladstone Institutes
Dr. Robert Grant writes for the Huffington Post about use PrEP to finally end HIV transmission in San Francisco
Dr. Leor Weinberger discusses possible treatments for Ebola with ABC 7 News and stresses the need for research into new anti-virals that can treat a broad range of infections.
The ALS Association announces initial commitment of $21.7 million from Ice Bucket Challenge donations to expedite search for treatments and a cure for ALS
Gladstone investigator Dr. Steven Finkbeiner is part of a consortium receiving funding from the ALS Association Ice Bucket Challenge donations, investigating new potential treatments for ALS.
Dr. Deepak Srivastava, Director of the Gladstone Institute of Cardiovascular Disease, discusses the future of cardiac reprogramming, the potentially life-saving technique that he pioneered.
The Gladstone Institutes Dr. Robert Grant, who led the research on Truvada, confirms that the drug is safe and highly effective.
Gladstone senior investigator Dr. Robert Grant recommends PrEP for HIV prevention be used like contraception.